๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Solid Tumor, Adult

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors NCT07414836Phase 118 sites๐Ÿ“ Boston๐Ÿ“ St Louis๐Ÿ“ Hackensack BeOne Medicines ยท Tests: BG-C0979, Tislelizumab An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors NCT07222267Phase 132 sites๐Ÿ“ Birmingham๐Ÿ“ New Haven๐Ÿ“ St Louis BeOne Medicines ยท Tests: BG-75202, CDK4 Inhibitor, Estrogen Receptor Antagonist, Aromatase Inhibitor ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) NCT06415487Phase 19 sites๐Ÿ“ San Diego๐Ÿ“ Denver๐Ÿ“ Nashville Acepodia Biotech, Inc. ยท Tests: Cyclophosphamide, Fludarabine, ACE2016, Pembrolizumab COAST Therapy in Advanced Solid Tumors and Prostate Cancer NCT05036226Phase 1, Phase 21 site๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Hydroxychloroquine, Metformin, Sirolimus, Hydroxychloroquine, Metformin, Sirolimus, Dasatanib, Hydroxychloroquine, Metfโ€ฆ A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells. NCT00571389n/a1 site๐Ÿ“ Huntersville BioCytics, Inc. Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours NCT06453057NA1 site๐Ÿ“ Shanghai Grit Biotechnology ยท Tests: GT307 injection Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ Stanford BioEclipse Therapeutics ยท Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma NCT07627698Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-DTKN-401 allogeneic dual-target CSPG4/GD2 CAR-NK cells, Fludarabine, Cyclophosphamide IMA402 T Cell-Engaging Receptor Molecule (TCERยฎ) in Recurrent and/or Refractory Solid Tumors NCT05958121Phase 1, Phase 229 sites๐Ÿ“ Heidelberg๐Ÿ“ Heidelberg๐Ÿ“ Mannheim Immatics Biotechnologies GmbH ยท Tests: IMA402, IMA402 and checkpoint inhibitor, IMA402 and chemotherapy, IMA402 and IMA401, IMA402 and monoclonal antibody KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors NCT06026410Phase 138 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Kura Oncology, Inc. ยท Tests: Darlifarnib, Cabozantinib, Adagrasib A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement NCT07359820Phase 219 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Tampa Elevar Therapeutics ยท Tests: Lirafugratinib EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC NCT07617805Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EGFR/HER2 Dual-Target CAR-NK Cells, Fludarabine, Cyclophosphamide A Study of GC203 TIL in Advanced Solid Tumors (NF) NCT07256756Phase 11 site๐Ÿ“ Shenzhen Shanghai Juncell Therapeutics ยท Tests: GC203 TIL A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors NCT07361562Phase 115 sites๐Ÿ“ Scottsdale๐Ÿ“ Scottsdale๐Ÿ“ New Haven Cogent Biosciences, Inc. ยท Tests: CGT4255 Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors NCT04165772Phase 210 sites๐Ÿ“ Hartford๐Ÿ“ Miami๐Ÿ“ Basking Ridge Memorial Sloan Kettering Cancer Center ยท Tests: TSR-042 or Dostarlimab, capecitabine or 5-FU, Intensity Modulated Radiation Therapy (IMRT) Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers NCT07493304Phase 313 sites๐Ÿ“ Hialeah๐Ÿ“ New York๐Ÿ“ El Paso Regeneron Pharmaceuticals ยท Tests: REGN7508, Apixaban A Study of PHST001 in Advanced Solid Tumors NCT06840886Phase 120 sites๐Ÿ“ Beverly Hills๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto Pheast Therapeutics ยท Tests: PHST001, Paclitaxel, Topotecan, Doxorubicin, FOLFIRI A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab NCT07391670Phase 119 sites๐Ÿ“ Fitzroy๐Ÿ“ St Albans๐Ÿ“ Woolloongabba AstraZeneca ยท Tests: SC durvalumab + rHu, IV durvalumab, Tremelimumab Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors NCT05055609Phase 12 sites๐Ÿ“ Santa Monica๐Ÿ“ Huntersville Trethera ยท Tests: TRE-515 Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors NCT06840821Phase 1, Phase 21 site๐Ÿ“ Jinan Mainline Biosciences (Shanghai) Co., Ltd ยท Tests: MB0151 for injection Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors NCT06770764Phase 11 site๐Ÿ“ Scottsdale Trutino Biosciences Inc. ยท Tests: ODC-IL2 A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors NCT05866692Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Jinan TYK Medicines, Inc ยท Tests: TY-2699a Dabrafenib and/or Trametinib Rollover Study NCT03340506Phase 438 sites๐Ÿ“ Scottsdale๐Ÿ“ Bethesda๐Ÿ“ Columbus Novartis Pharmaceuticals ยท Tests: dabrafenib, trametinib Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors NCT05372640Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles National Cancer Institute (NCI) ยท Tests: Abemaciclib, BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840Phase 148 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Duarte Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene. NCT07192068Phase 24 sites๐Ÿ“ Angers๐Ÿ“ Marseille๐Ÿ“ Vandล“uvre-lรจs-Nancy UNICANCER ยท Tests: Zanidatamab Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) NCT07432295Phase 26 sites๐Ÿ“ Goodyear๐Ÿ“ Duarte๐Ÿ“ Boston I-Mab Biopharma US Limited ยท Tests: Givastomig, Nivolumab, 5Fluorouracil, Leucovorin, Oxaliplatin Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors NCT05856981Phase 17 sites๐Ÿ“ Detroit๐Ÿ“ St Louis๐Ÿ“ Canton Sairopa B.V. ยท Tests: ADU-1805, Pembrolizumab ACTengineยฎ IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors NCT03686124Phase 1, Phase 221 sites๐Ÿ“ Stanford๐Ÿ“ Aurora๐Ÿ“ Miami Immatics US, Inc. ยท Tests: IMA203 Product, IMA203 product- flat dose, IMA203CD8 Product, Nivolumab, IMADetectยฎ PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor NCT06883149Phase 11 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: PIN +anti-PD1
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy